EMEA-001238-PIP01-12 - paediatric investigation plan

alpha tocotrienol quinone

Key facts

• Active substance:
  alpha tocotrienol quinone
• Therapeutic area:
  Neurology
• Decision number:
  P/0174/2013
• PIP number:
  EMEA-001238-PIP01-12
• Pharmaceutical form(s):
  Oral solution
• Condition(s) / indication(s):
  Treatment of Leigh syndrome
• Route(s) of administration:
  • Oral use
  • Enteral use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  30/07/2013
• Compliance check done:
  No

Decision

P/0174/2013: EMA decision of 30 July 2013 on the agreement of a paediatric investigation plan and on the granting of a deferral for alpha tocotrienol quinone (EMEA-001238-PIP01-12)

Adopted Reference Number: EMA/393021/2013